MedLife reports net profit down 19.4%, to 10.5 million RON, in first quarter

MedLife obtained a net profit of 10.56 million RON in the first quarter of this year, down 19.42% compared to the net result achieved in the first quarter of 2024, according to a company report submitted to the Bucharest Stock Exchange.The pro-forma consolidated turnover reached 779 million RON, up 20% compared to the same period of the previous year. The group also reported an increase in EBITDA, compared to the first three months of last year, reaching a value of 116 million RON."The results of the first quarter look good, both in terms of revenue and EBITDA, and confirm that we are on a good trend. MedLife remains the leader in the private medical services market in Romania and, at the same time, consolidates its position as a technologically advanced company through cutting-edge solutions that transform the patient experience. In fact, we have become, probably, the most technologically advanced company in this sector at the regional level, with state-of-the-art solutions, such as drones for transporting samples, robots for surgical interventions, Artificial Intelligence directly in the application and many of the fully automated processes," declared Mihai Marcu, President and CEO of MedLife Group, quoted in the press release.In general terms, the demand for medical services, especially in the area of prevention, increased, being enhanced by a strong recognition of the quality of doctors within the national network, of medical technology, as well as of the quality of the medical act. Most of the business lines of the MedLife Group recorded a good performance, compared to the same period of the previous year. Thus, the highest increases were recorded by hospitals (+38.5%), followed by laboratories (+26.9%) and clinics (+17.5%).At the same time, the first months of 2025 were marked by the official entry into a new international market and the expansion of the network beyond the country's borders by taking over the majority stake in All Clinic in the Republic of Moldova. MedLife also completed the acquisition of the Routine Med group in Tulcea, continuing the sustainable development strategy at the national level and strengthening the presence in key areas.Regarding the evolution of the corporate division, the Group managed to maintain a solid portfolio in the first quarter of this year, with over 886,000 active subscriptions.MedLife mentions that it announced in the first quarter of this year the increase of the syndicated credit limit by 50 million euros, thus reaching a total of 330 million euros. This decision is an integral part of the strategy to consolidate the financial position and support the projects already underway, and the additional funds will be used mainly for their completion, but also for possible acquisition opportunities.The MedLife Group has over 6.5 million unique patients who have used prevention, wellness, treatment and hospitalization services.The shares issued by MedLife SA are admitted to trading on the regulated spot market administered by the Bucharest Stock Exchange, Premium Category, with the trading symbol "M".